Keyphrases
ARA290
100%
Burn Depth
16%
Burn Injury
33%
Burned Area
16%
CD131
16%
Clinical Setting
16%
Cutaneous Burn
100%
Erythropoietin
100%
Erythropoietin Derivatives
16%
Erythropoietin Receptor
33%
Full-thickness
16%
Full-thickness Burns
16%
Helix
16%
Hemorrhagic Shock
16%
Heteromer
16%
Homodimer
16%
Injury Model
16%
Injury Type
16%
Innate Inflammatory Response
16%
Long-term Recovery
16%
Microvascular Inflammation
100%
Microvasculature
16%
Myocardial Infarction
16%
Necrosis
16%
Partial Thickness
16%
Patency
16%
Postburn
33%
Protective Behavior
16%
Protective Properties
16%
Secondary Wound Closure
16%
Skin Graft
16%
Surgical Debridement
16%
Surrounding Tissues
16%
Systemic Administration
16%
Therapeutic Approaches
16%
Tissue Components
16%
Tissue Damage
16%
Tumor Necrosis Factor-α
16%
Vascular Thrombosis
100%
Viable Tissue
16%
Medicine and Dentistry
Back
16%
Cibinetide
100%
Debridement
16%
Erythropoietin
100%
Erythropoietin Receptor
33%
Helix
16%
Hemorrhagic Shock
16%
Homodimer
16%
Microvessel
16%
Myocardial Infarction
16%
Necrosis
16%
Receptor
33%
Serositis
16%
Skin Transplantation
16%
Systemic Administration
16%
Thermal Burn
100%
Thrombosis
100%
Tissue Injury
16%
Tumor Necrosis Factor
16%
Wound Care
16%
Wound Closure
16%
Pharmacology, Toxicology and Pharmaceutical Science
Burn
100%
Cibinetide
100%
Erythropoietin
100%
Erythropoietin Receptor
33%
Heart Infarction
16%
Hemorrhagic Shock
16%
Homodimer
16%
Inflammation
100%
Necrosis
16%
Receptor
33%
Systemic Administration
16%
Thrombosis
100%
Tissue Injury
16%
Tumor Necrosis Factor
16%
Wound
33%